IPP Bureau
T-CURX gets Swissmedic nod for first human trial of non-viral CAR-T therapy
By IPP Bureau - June 15, 2026
Phase 1 study to evaluate Siglec-6-targeted CAR-T therapy in relapsed or refractory AML and CLL patients, marking a major milestone for T-CURX’s scalable non-viral CAR-T platform
Ramkrishna CARE Hospitals’s dedicated cancer institute to open in August 2026
By IPP Bureau - June 15, 2026
The new institute will strengthen oncology infrastructure in central India with advanced radiation therapy, multidisciplinary expertise, and comprehensive cancer care services
Dr Reddy’s launches first-to-market generic Bosutinib in US oncology push
By IPP Bureau - June 15, 2026
Dr Reddy’s has partnered with MSN Laboratories Private Limited on the product, with Dr Reddy’s holding exclusive US marketing rights while MSN leads development and manufacturing
Arihant Innochem launches state-of-the-art research & innovation centre in Navi Mumbai
By IPP Bureau - June 15, 2026
The new facility aims to accelerate formulation science and application-led research across pharma, biopharma, nutraceuticals, personal care, and home care segments
Leprosy elimination drive intensifies as Indian govt pushes high-burden states toward zero transmission goal
By IPP Bureau - June 15, 2026
Patnaik stressed early diagnosis, rapid treatment, and aggressive surveillance as the backbone of elimination efforts
Cohere Health’s Global Innovation Centre recognized as impactful at ET Edge GCC Summit
By IPP Bureau - June 15, 2026
Award highlights Hyderabad-based innovation hub’s role in advancing healthcare technology, clinical intelligence, and global operational excellence
Cohance Lifesciences shareholders back Umang Vohra as Chairman and Group CEO
By IPP Bureau - June 15, 2026
Postal ballot also clears remuneration proposal and new ESOP 2026 scheme, strengthening the company’s leadership and talent retention strategy
Redcliffe Labs expands Rajasthan footprint with strategic acquisition
By IPP Bureau - June 15, 2026
Acquisition strengthens integrated radiology and pathology capabilities, enhancing access to advanced diagnostics and preventive healthcare
PULSUS targets 6,000 jobs at Rs. 500 crore Ameenpur AI Healthcare Hub
By IPP Bureau - June 15, 2026
Supreme Court grants PULSUS Ameenpur project ITeS Park and SEZ status, strengthening Telangana's position in AI, healthcare technology, and digital services
ZoBio launches DEL platform to accelerate drug discovery for challenging targets
By IPP Bureau - June 15, 2026
New hit discovery service combines integrated DNA-Encoded Library screening, structural biology, biophysics, and X-ray crystallography
Medtronic launches PulseSelect PFA system in India
By IPP Bureau - June 15, 2026
New-generation cardiac ablation technology expands treatment options for atrial fibrillation patients, offering a non-thermal approach to improve safety and procedural efficiency
Maiva Pharma inaugurates advanced sterile injectables manufacturing facility in Tamil Nadu
By IPP Bureau - June 15, 2026
New Shoolagiri plant strengthens Maiva’s global CDMO capabilities with advanced isolator technology, flexible production lines, and expanded capacity for complex injectable therapies
Lonza, Antharis partner to develop next-generation dual-payload ADCs for GI cancers
By IPP Bureau - June 15, 2026
Exclusive licensing agreement combines Lonza’s dual-payload ADC technology with Antharis’ antibody engineering expertise
Suven Life Sciences to showcase narcolepsy program Samelisant at SLEEP 2026
By IPP Bureau - June 14, 2026
Samelisant will be the centerpiece of Suven’s scientific presence
Alembic secures USFDA nod for Tretinoin Cream strengthening generics portfolio
By IPP Bureau - June 14, 2026
The approval clears the company to market a generic version that is therapeutically equivalent to Retin-A Cream
